T1324

O-Phospho-L-serine (Phosphoserine) is the phosphoric acid ester of serine.

UB 165 fumarate is an agonist of the nAChR, a partial agonist of the α4β2 subtype, and a full agonist of the α3β2 subtype, with a Ki value of 0.27 nM for binding to [3H]-nicotine measured in rat brain.

UK-101 is a small molecule inhibitor and a selective inhibitor of the immunoproteasome β1i (LMP2) subunit (IC50=104 nM), with 144-fold and 10-fold selectivity over the β1c and β5 subunits, respectively. This compound can induce apoptosis, possesses antitumor activity, and can be used for prostate cancer-related research.

UK-240455 is a potent and selective N-methyl-D-aspartic acid (NMDA) glycine receptor antagonist with neuroprotective effects and improvements in motor function in Parkinson's disease models, making it a potential candidate for Parkinson's disease treatment.

Ubiquinol, the biologically active reduced form of coenzyme Q10 (CoQ10), Ubiquinol exerts its potent bioenergetic and antioxidant effects through the redox capability of its benzoquinone head group to accept and donate electrons, making it a promising therapeutic candidate for improving muscle function and physical performance.

U91356 is an agonist of the dopamine receptors.

UbcH5c-IN-1 is a selective small-molecule Ubiquitin-conjugating enzyme UbcH5c inhibitor (Kd: 283 nM for E2 UbcH5c-IN-1 by covalent binding with Cys85).

Ubiquitination-IN-1 is an inhibitor of ubiquitination and Cksl-Skp2 protein-protein interaction (IC50: 0.17 μM).

UCSF924 is a potent and specific agonist of the dopamine D4 receptor (DRD4) with an EC50 of 4.2 nM and a Ki of 3 nM.

UCT943 is an inhibitor of Plasmodium falciparum PI4K (IC50 = 23 nM).

UK-370106 is a potent and highly selective inhibitor of MMP-3 (IC50: 23 nM) and MMP-12 (IC50: 42 nM), effectively inhibiting the cleavage of [3H]-fibronectin by MMP-3 (IC50: 320 nM).